Structural Brain Abnormalities in Adolescent Anorexia Nervosa Before and After Weight Recovery and Associated Hormonal Changes

2012 ◽  
Vol 74 (6) ◽  
pp. 574-582 ◽  
Author(s):  
Verena Mainz ◽  
Martin Schulte-Rüther ◽  
Gereon R. Fink ◽  
Beate Herpertz-Dahlmann ◽  
Kerstin Konrad
1997 ◽  
Vol 19 (1) ◽  
pp. 20-33 ◽  
Author(s):  
Susan J. Bradley ◽  
Margot J. Taylor ◽  
Joanne F. Rovet ◽  
Eudice Goldberg ◽  
Jane Hood ◽  
...  

Author(s):  
Takeshi Asami ◽  
Masao Takaishi ◽  
Ryota Nakamura ◽  
Asuka Yoshimi ◽  
Jun Konishi ◽  
...  

1982 ◽  
Vol 99 (3) ◽  
pp. 334-338 ◽  
Author(s):  
B. Baranowska ◽  
S. Zgliczyński

Abstract. In order to elucidate the mechanism of impaired LH secretion, 60 female patients with anorexia nervosa were investigated. A control group consisted of 14 women of the same age, examined in the follicular phase of the menstrual cycle. The serum LH, FSH, prolactin, TSH, testosterone, dihydrotestosterone, dehydroepiandrosterone, Δ 4-androstenedione, oestrone, oestradiol, oestriol, progesterone, thyroxine, triiodothyronine, reverse T3 and serum sex hormone binding globulin (SHBG) concentrations were measured. The results showed a significant increase in serum dehydroepiandrosterone, testosterone, oestriol and reverse T3 concentrations. However, oestrone, oestradiol, progesterone, SHBG and triiodothyronine levels were significantly lower than those of the control group. The mean serum LH concentration in patients with anorexia nervosa before and after LRH stimulation was significantly lower than that in the control group, but FSH secretion in response to LRH was normal. All hormonal changes in anorexia nervosa disappeared after weight gain during cyproheptadine treatment. Dramatically increased dehydroepiandrosterone levels suggest that the high testosterone in women with anorexia nervosa is derived from adrenal rather than from gonadal steroids. There was no correlation between serum testosterone, dehydroepiandrosterone, oestriol and LH concentrations indicating that steroid hormone disturbances do not cause impaired LH release in anorexia nervosa.


2011 ◽  
Vol 118 (6) ◽  
pp. 963-968 ◽  
Author(s):  
Katharina Buehren ◽  
Kerstin Konrad ◽  
Kerstin Schaefer ◽  
Juergen Kratzsch ◽  
Berak Kahraman-Lanzerath ◽  
...  

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Melissa J Dreier ◽  
Avery L. Van De Water ◽  
Danielle L. Kahn ◽  
Kendra R. Becker ◽  
Kamryn T. Eddy ◽  
...  

Abstract Background Anorexia nervosa (AN) is associated with structural brain abnormalities. Studies have reported less cerebral tissue and more cerebrospinal fluid (CSF) in individuals with AN relative to healthy controls, although findings are variable and inconsistent due to variations in sample size, age, and disease state (e.g., active AN, weight-recovered AN). Further, it remains unclear if structural brain abnormalities observed in AN are a consequence of specific brain pathologies or malnutrition, as very few longitudinal neuroimaging studies in AN have been completed. Methods To overcome this issue, this comprehensive meta-analysis will combine region-of-interest (ROI) and voxel-based morphometry (VBM) approaches to understand how regional and global structural brain abnormalities differ among individuals with AN and healthy controls (HCs). Additionally, we aim to understand how clinical characteristics and physiological changes during the course of illness, including acute illness vs. weight recovery, may moderate these structural abnormalities. We will create an online database of studies that have investigated structural brain abnormalities in AN. Data will be reviewed independently by two members of our team using MEDLINE databases, Web of Science, PsycINFO, EMBASE, and CINAHL. We will conduct ROI and VBM meta-analysis using seed-based d mapping in AN and HCs. We will include all studies that include structural neuroimaging of individuals with AN (both acute and weight-recovered) and HCs between January 1997 and 2020. Discussion This systematic review will assess the effects of AN compared to HC on brain structure. Futhermore, it will explore the role of acute AN and weight-recovered AN on brain structure. Findings will help researchers and clinicians to better understand the course of illness in AN and the nature of recovery, in terms of weight, malnutrition, and the state of the brain. Systematic review registration PROSPERO CRD42020180921


Author(s):  
S.K. Aggarwal ◽  
J.M. Fadool

Cisplatin (CDDP) a potent antitumor agent suffers from severe toxic side effects with nephrotoxicity being the major dose-limiting factor, The primary mechanism of its action has been proposed to be through its cross-linking DNA strands. It has also been shown to inactivate various transport enzymes and induce hypocalcemia and hypomagnesemia that may be the underlying cause for some of its toxicities. The present is an effort to study its influence on the parathyroid gland for any hormonal changes that control calcium levels in the body.Male Swiss Wistar rats (Crl: (WI) BR) weighing 200-300 g and of 60 days in age were injected (ip) with cisplatin (7mg/kg in normal saline). The controls received saline injections only. The animals were injected (iv) with calcium (0.5 ml of 10% calcium gluconate/day) and were killed by decapitation on day 1 through 5. Trunk blood was collected in heparinized tubes.


Sign in / Sign up

Export Citation Format

Share Document